Lipella Pharmaceuticals Inc. Marketable Securities, Unrealized Gain (Loss)
Lipella Pharmaceuticals Inc. (LIPO) reported Marketable Securities, Unrealized Gain (Loss) of -$29 for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2023-03-31
- Lipella Pharmaceuticals Inc. marketable securities, unrealized gain (loss) for fiscal 2021 was -$29.00.
| Period end | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|
| 2021-12-31 | -$29.00 10-K · filed 2023-03-31 |